The France Journal
SEE OTHER BRANDS

The top news stories from France

The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on July 18, 2025

2ème Édition Fonds de Recherche Dermatologie Galénic

2ème Édition Fonds de Recherche Dermatologie Galénic

PARIS, FRANCE, July 18, 2025 /⁨EINPresswire.com⁩/ -- FONDS DE RECHERCHE DERMATOLOGIE GALÉNIC LE FONDS RÉCOMPENSE SIX PROJETS INNOVANTS EN DERMATOLOGIE Poitiers, le 26 juin 2025 Pour sa deuxième édition, le Galénic Dermatology Research Fund a …

Devyzz is launching Devyzz Sport, in partnership with Sebastien Haller

Devyzz is launching Devyzz Sport, in partnership with Sebastien Haller

Devyzz is partnering with a top-tier football player to reshape how professional athletes manage their cross-border payments. PARIS, PARIS, FRANCE, July 18, 2025 /⁨EINPresswire.com⁩/ -- Devyzz is proud to announce the official launch of Devyzz Sport, its …

21Shares Files for 21Shares FTSE Crypto 10 Index ETF and 21Shares FTSE Crypto 10 ex-BTC Index ETF

21Shares Files for 21Shares FTSE Crypto 10 Index ETF and 21Shares FTSE Crypto 10 ex-BTC Index ETF

NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- 21Shares US LLC today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) for two Funds, the 21Shares FTSE Crypto 10 Index ETF and the 21Shares FTSE Crypto …

Guestadom lance sa plateforme de conciergerie et de location de courte durée, 100 % française et à services modulables

Guestadom lance sa plateforme de conciergerie et de location de courte durée, 100 % française et à services modulables

LAVAL, France, 18 juill. 2025 (GLOBE NEWSWIRE) -- Guestadom annonce le lancement officiel de sa plateforme dédiée à la gestion de locations de courte durée. Créée par une conciergerie expérimentée, Guestadom propose une solution 3-en-1 unique en France, …

Results of the Stellantis 2025 Extraordinary General Meeting of Shareholders

Results of the Stellantis 2025 Extraordinary General Meeting of Shareholders

Results of the Stellantis 2025 Extraordinary General Meeting of Shareholders AMSTERDAM, July 18, 2025 – Stellantis N.V. (“Stellantis”) announced today that shareholders approved the appointment of Antonio Filosa as a member of the Board of Directors and an …

ImCheck’s ICT01 Receives FDA Orphan Drug Designation  for Treatment of Acute Myeloid Leukemia

ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia

ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials Marseille, France, July 18, 2025, …

Le Groupe Bonduelle confirme la cession de son activité de salade en sachet en France

Le Groupe Bonduelle confirme la cession de son activité de salade en sachet en France

BONDUELLE Siège social - "La Woestyne" - 59173 Renescure - France Bonduelle SCA - Société en commandite par actions au capital de 57 102 699,50 euros RCS DUNKERQUE 447 250 044 Communiqué de presse Villeneuve d’Ascq, le 18 juillet 2025 Le Groupe Bonduelle …

The Bonduelle Group confirms the sale of its packaged salad business in France

The Bonduelle Group confirms the sale of its packaged salad business in France

BONDUELLE  Head office: "La Woestyne" - 59173 Renescure - France Bonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 euros Registered under number : 447 250 044 ( Dunkerque Commercial and Companies Register) Press …

Press Release: Sanofi completes acquisition of Blueprint Medicines

Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, and …

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines

Sanofi finalise l’acquisition de Blueprint Medicines Paris, le 18 juillet 2025. Sanofi annonce aujourd’hui la finalisation de l’acquisition de Blueprint Medicines Corporation (Blueprint). La nouvelle entreprise ajoute au portefeuille de Sanofi des …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions